Is Probiotic Strains safe?
Searched over 200M research papers
Research Analysis by Consensus
Beta · 20 papersConsensus Meter
Yes0%
Possibly0%
No0%
Probiotics, live microorganisms that confer health benefits to the host, are widely consumed globally and are generally considered safe. However, their safety profile is not uniform across all strains and populations, necessitating a nuanced understanding of their use.
Key insights from the research papers include:
- Probiotics, particularly strains from the genera Bifidobacterium and Lactobacillus, are largely safe but can cause adverse effects such as sepsis, fungemia, and gastrointestinal ischemia in at-risk populations like critically ill patients, infants, postoperative patients, and those with compromised immune systems.
- Lactic acid bacteria, commonly used in probiotics, have a long history of safe use and are often granted GRAS (Generally Recognized As Safe) status, although some strains may carry opportunistic pathogens or antibiotic resistance genes that could pose safety concerns .
- Rare cases of bacteremia or fungemia have been associated with probiotic use, but epidemiological evidence does not suggest an increased population risk based on usage data. Controlled clinical trials generally support the safe use of probiotics.
- Probiotic translocation is rare in healthy individuals and usually does not lead to negative effects, but in immunocompromised patients, it can cause health-damaging effects, and the antibiotic resistance of some strains may complicate treatment.
- Specific probiotic strains, such as Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019, have been shown to be safe and well-tolerated in infants, without affecting normal growth.
- While the long history of probiotic use and data from various studies support the assumption that probiotics are generally safe, more research is needed to fully understand the incidence and severity of adverse events related to their use.
- A comprehensive review of randomized controlled trials (RCTs) found limited evidence to address safety concerns confidently, highlighting the need for studies designed specifically to assess the safety of probiotics.
- The safety of new and emerging probiotic strains should be assessed comprehensively on a case-by-case basis, as they may not have a documented history of safe use.
- The safety of probiotics should be considered on a strain-by-strain basis, taking into account the dose, interaction with other strains, and the specific health conditions of the consumer.
In conclusion, the majority of probiotic strains, particularly those with a long history of use in foods, are considered safe for the general population. However, caution is advised when administering probiotics to at-risk individuals, such as those with compromised immune systems or critical illnesses. The safety of new probiotic strains should be evaluated on an individual basis, and the potential for antibiotic resistance transfer should be considered. Overall, while probiotics are generally safe, their use should be accompanied by a thorough risk-benefit assessment, especially in vulnerable populations.
Sources and full results
Most relevant research papers on this topic